alpha-aminopyridine has been researched along with Cirrhosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Bihouee, T; Bonnel, AS; Chedevergne, F; Ciciriello, F; Cornet, M; Kelly, M; Lebourgeois, M; Lucidi, V; Marguet, C; Reix, P; Robin, G; Roy, V; Sermet-Gaudelus, I; Stoven, V | 1 |
| Jiang, C; Lu, Y; Zhang, S | 1 |
| Asano, Y; Fukushima, S; Hashizume, Y; Ide, M; Ihn, H; Jinnin, M; Kajihara, I; Tomizawa, Y; Wang, Z | 1 |
| Doi, S; Doi, T; Masaki, T; Nakashima, A; Sasaki, K; Soji, K | 1 |
| Gao, J; Hill, JA; Kass, DA; Kokkonen-Simon, KM; Kyrychenko, V; Liao, L; Liu, ZP; Luo, X; Martinez, ED; Olson, EN; Ranek, MJ; Tan, W; Tran, TAT; Wang, M; Xu, J; Zhang, QJ | 1 |
| Acquaviva, A; Arezzini, B; Gardi, C; Martorana, PA; Tenor, H; Vecchio, D | 1 |
| DeNardo, DG; Hawkins, WG; Hegde, S; Herndon, JM; Jiang, H; Knolhoff, BL; Meyer, MA; Nywening, TM; Pachter, JA; Shapiro, IM; Wang-Gillam, A; Weaver, DT; Zhu, Y | 1 |
| Althage, A; Beyer, C; Chen, CW; Cole, SH; Distler, JH; Gergely, P; Harris, JL; Hsieh, MH; Li, C; Liu, J; Maier, C; Meeusen, S; Ng, N; Pan, S; Schett, G; Seidel, HM; Svensson, EC; Trinh-Minh, T; Xu, X | 1 |
| Amaro, M; Birnbaum, MJ; Bollinger, E; Boucher, GG; Calabrese, MF; Cameron, KO; Cialdea, K; Cokorinos, E; Coskran, TM; DaSilva-Jardine, P; Edmonds, DJ; Gandhok, H; Genung, NE; Jatkar, A; Kalgutkar, AS; Kreeger, JM; Kurumbail, RG; Maciejewski, BS; Miller, RA; Monetti, M; Opsahl, AC; Rajamohan, F; Reyes, A; Rolph, T; Salatto, CT; Shavnya, A; Tess, DA; Ward, J | 1 |
9 other study(ies) available for alpha-aminopyridine and Cirrhosis
| Article | Year |
|---|---|
Profiling the response to lumacaftor-ivacaftor in children with cystic between fibrosis and new insight from a French-Italian real-life cohort.
Topics: Adolescent; Aminophenols; Aminopyridines; Anti-Bacterial Agents; Benzodioxoles; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Fibrosis; Forced Expiratory Volume; Humans; Mutation | 2022 |
Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
Topics: Aminopyridines; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart; Humans; Hydrazones; Jumonji Domain-Containing Histone Demethylases; Myocardium; Myocytes, Cardiac; Oxidoreductases, N-Demethylating; Rats; RNA, Small Interfering; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1 | 2020 |
Transforming growth factor β-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis.
Topics: Actins; Amino Acids; Aminopyridines; Animals; Bleomycin; Collagen Type I; Collagen Type I, alpha 1 Chain; Connective Tissue Growth Factor; Fibroblasts; Fibrosis; Humans; Inhibitory Concentration 50; Mice; Phenols; Pyrazoles; Pyridines; Pyrroles; Scleroderma, Systemic; Signal Transduction; Skin; Transforming Growth Factor beta; Up-Regulation; Xanthenes | 2017 |
Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction.
Topics: Aminopyridines; Animals; Cell Line; Deubiquitinating Enzymes; Down-Regulation; Enzyme Inhibitors; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Rats; Smad2 Protein; Thiocyanates; Ureteral Obstruction | 2018 |
Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis.
Topics: Aminopyridines; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Histone Demethylases; Humans; Hydrazones; Mice, Knockout; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Rats, Sprague-Dawley | 2018 |
Downregulation of NOX4 expression by roflumilast N-oxide reduces markers of fibrosis in lung fibroblasts.
Topics: Aminopyridines; Benzamides; Cell Proliferation; Cells, Cultured; Collagen; Cyclopropanes; Dinoprost; DNA; Down-Regulation; Enzyme Inhibitors; Fibroblasts; Fibrosis; Gene Expression Regulation, Enzymologic; Humans; Lung; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Oxygen; Reactive Oxygen Species | 2013 |
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
Topics: Aminopyridines; Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; CD8-Positive T-Lymphocytes; Cell Proliferation; Deoxycytidine; Disease Models, Animal; Disease Progression; Fibrosis; Focal Adhesion Protein-Tyrosine Kinases; Gemcitabine; Humans; Immunoblotting; Immunohistochemistry; Immunotherapy; Immunotherapy, Adoptive; Mice; Pancreatic Neoplasms; Programmed Cell Death 1 Receptor; Reverse Transcriptase Polymerase Chain Reaction; Tumor Escape; Tumor Microenvironment | 2016 |
Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling.
Topics: Acyltransferases; Aminopyridines; Animals; Bleomycin; Disease Models, Animal; Disease Progression; Female; Fibrosis; Graft vs Host Disease; Membrane Proteins; Mice, Inbred BALB C; Piperazines; Protein Serine-Threonine Kinases; Pulmonary Fibrosis; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Scleroderma, Localized; Scleroderma, Systemic; Skin; Transforming Growth Factor beta; Wnt Signaling Pathway | 2017 |
Selective Activation of AMPK
Topics: Aminopyridines; AMP-Activated Protein Kinases; Animals; Cell Size; Diabetic Nephropathies; Enzyme Activation; Enzyme Activators; Fibrosis; Humans; Indoles; Isoenzymes; Kidney; Kidney Function Tests; Macaca fascicularis; Mice, Inbred C57BL; Oxidative Stress; Phosphorylation; Proteinuria; Rats; Species Specificity | 2017 |